Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: A prospective follow-up study

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 578-581

  Jeong, Hwan Kim ^a   Joon, Hyoek Lee ^b   Sang, Jong Park ^b   Mun, Hee Bae ^b   Ji, Hyang Kim ^b   Do, Young Kim ^b   Jong, Kyu Kim ^b   Moon, Seok Choi ^b   Kwang, Cheol Koh ^b   Seung, Woon Paik ^b   Byung, Chul Yoo ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hepatitis B surface antigen; Hepatitis B virus; Prognosis; Seroclearance

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; NUCLEOTIDE DERIVATIVE; VIRUS DNA;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; KOREA; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 44349194322     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lee WM: Hepatitis B virus infection. N Engl J Med 1997; 337:1733-1745.
2. Ganem D, Prince AM: Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350:1118-1129.
3. Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2001; 34:1225-1241.
4. Lok AS: Chronic hepatitis B. N Engl J Med 2002; 346:1682-1683.
5. Lindsay KL, Redeker AG, Ashcavai M: Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1981; 1:586-589.
6. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC: Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991; 13:627-631.
7. Marrero JA, Lok AS: Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit? Gastroenterology 2004; 126:347-350.
8. Kato Y, Nakao K, Hamasaki K, Kato H, Nakata K, Kusumoto Y, Eguchi K: Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan. J Gastroenterol 2000; 35:201-205.
9. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD: Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998; 28:231-236.
10. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Crax A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G: Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126:102-110.
11. Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, Han KH, Park C, Moon YM, Chon CY: Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 2005; 42:188-194.
12. Kew MC: Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1981; 1:366-369.
13. Bae SH, Yoon SK, Jang JW, Kim CW, Nam SW, Choi JY, Kim BS, Park YM, Suzuki S, Sugauchi F, Mizoka mi M: Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J Korean Med Sci 2005; 20:816-820.
14. Manno M, Camma C, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E: Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology 2004; 127:756-763.
15. Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, Olivotto PG, Solinas A, Almasio P, Hadziyannis S, Degos F, de Moura MC, Krogsgaard K, Pantalena M, Realdi G, Corrocher R, Schalm SW: Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP). Am J Gastroenterol 1998; 93:896-900.
16. Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, Archimandritis AJ, Papoutselis K: Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol 2005; 77:173-179.
17. Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS: Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992; 15:382-386.
18. Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, Cote J, Richer G: A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106:1000-1005.
19. Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ: Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003; 98:2261-2267.
20. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, Castelnau C, Valla D, Degott C, Marcellin P: Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002; 36:543-546.